Abstract
Dyskeratosis congenita (DKC) is a paradigmatic telomere disorder characterized by substantial and premature telomere shortening, bone marrow failure, and a dramatically increased risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). DKC can occur as a late-onset, so-called cryptic form, with first manifestation in adults. Somatic MDS-related mutations are found in up to 35% of patients with acquired aplastic anemia (AA), especially in patients with short telomeres. The aim of our study was to investigate whether cryptic DKC is associated with an increased incidence of MDS-related somatic mutations, thereby linking the accelerated telomere shortening with the increased risk of MDS/AML. Samples from 15 adult patients (median age: 42 years, range: 23-60 years) with molecularly confirmed cryptic DKC were screened using next-generation gene panel sequencing to detect MDS-related somatic variants. Only one of the 15 patients (7%) demonstrated a clinically relevant MDS-related somatic variant. This incidence was dramatically lower than formerly described in acquired AA. Based on our data, we conclude that clonal evolution of subclones carrying MDS-related mutations is not the predominant mechanism for MDS/...Continue Reading
References
Dec 1, 1985·Cell·C W Greider, E H Blackburn
Feb 13, 2001·Blood·T H BrümmendorfP M Lansdorp
Apr 7, 2005·Blood·Fabian BeierTim H Brümmendorf
Sep 2, 2005·Nature Reviews. Genetics·Maria A Blasco
Aug 5, 2006·Leukemia·T H Brümmendorf, S Balabanov
Mar 14, 2009·Blood·Blanche P AlterPhilip S Rosenberg
Jul 1, 2011·The New England Journal of Medicine·Rafael BejarBenjamin L Ebert
Dec 14, 2011·Nature Genetics·Timothy A GraubertMatthew J Walter
Feb 22, 2012·American Journal of Human Genetics·Marjolijn C J JongmansRoland P Kuiper
Mar 16, 2012·The New England Journal of Medicine·Matthew J WalterTimothy A Graubert
Aug 21, 2014·Blood·Austin G KulasekararajGhulam J Mufti
Sep 23, 2014·Blood·Danielle M TownsleyNeal S Young
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
May 2, 2015·Blood·David P SteensmaBenjamin L Ebert
May 13, 2015·Cancer Cell·Cara Lunn ShiraiMatthew J Walter
Oct 16, 2015·ELife·Benjamin WernerArne Traulsen
Feb 26, 2016·Oncotarget·Carola I WeidnerWolfgang Wagner
Oct 22, 2016·American Journal of Hematology·Nieves PerdigonesMonica Bessler
Oct 18, 2016·Deutsche medizinische Wochenschrift·Karla SchmittTim H Brümmendorf
Nov 12, 2016·Nature Reviews. Cancer·Adam S SperlingBenjamin L Ebert
Jan 21, 2017·British Journal of Haematology·Natasha StanleyDaria V Babushok
Mar 4, 2017·The Journal of Cell Biology·Paula Martínez, Maria A Blasco
Jul 13, 2017·British Journal of Haematology·Hee S ParkDong S Lee
Oct 20, 2017·Blood·James N Cooper, Neal S Young
Oct 21, 2017·Haematologica·Blanche P AlterPhilip S Rosenberg
Citations
Sep 4, 2019·Expert Review of Hematology·Marena R Niewisch, Sharon A Savage
Mar 10, 2020·International Journal of Laboratory Hematology·Kazuki TeradaTakashi Okada
Aug 4, 2020·British Journal of Haematology·Martin KirschnerFabian Beier
Sep 7, 2018·Leukemia·Elina A M HirvonenUlla Wartiovaara-Kautto
Aug 18, 2018·Leukemia·Lijuan HanSteffen Koschmieder
Oct 28, 2019·Annals of the New York Academy of Sciences·Monica S Ventura FerreiraFabian Beier
Aug 21, 2020·Clinical Epigenetics·Olivia CyprisWolfgang Wagner
Mar 8, 2019·Leukemia·Maja Kim KuepperMirle Schemionek
Oct 13, 2020·Frontiers in Physiology·Khanh N DinhMarek Kimmel
Apr 4, 2021·International Journal of Molecular Sciences·Elena CrisàAndrea Patriarca
Aug 15, 2021·Annals of Hematology·Julian BaumeisterDeniz Gezer
Aug 19, 2021·Best Practice & Research. Clinical Haematology·Fernanda Gutierrez-RodriguesNeal S Young
Sep 28, 2021·Orphanet Journal of Rare Diseases·Mareike TomettenFabian Beier
Dec 11, 2021·Hematology·Haruna Batzorig ChoijilsurenMoonjung Jung